BioHarvest Sciences Inc. - SIC # 2840 -

Ticker Exchange SIC # Website Latest Ticker
BHST Nasdaq 2840 www.bioharvest.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for BioHarvest Sciences Inc.

Dow Jones continues to fall as oil prices climb - Mar 5th, 2026 1:49 pm
BioHarvest appoints former Israeli health chief Hezi Levy to board - Mar 5th, 2026 7:21 am
BioHarvest Sciences Announces Board Transition and Appointment of Prof. Hezi Levy - Mar 5th, 2026 5:30 am
BioHarvest Sciences to Participate in 38th Annual Roth Conference on March 22-24, 2026 - Mar 3rd, 2026 6:30 am
BioHarvest Sciences Inc. (NASDAQ:BHST): Is Breakeven Near? - Feb 16th, 2026 3:13 am
Is BioHarvest Sciences (BHST) a Long-Term Compounder? - Jan 23rd, 2026 5:13 am
BioHarvest Sciences Issues Year End Shareholder Letter - Jan 7th, 2026 5:30 am
The past five years for BioHarvest Sciences (NASDAQ:BHST) investors has not been profitable - Jan 6th, 2026 4:23 am
BioHarvest Sciences Awarded $1.6 Million USD Grant from the Israeli Innovation Authority to Advance Second-Generation Botanical Synthesis Platform - Dec 18th, 2025 5:30 am
BioHarvest Sciences Announces Launch of VINIA Blood Flow Hydration Product - Dec 3rd, 2025 5:30 am
BioHarvest Sciences Inc (BHST) Q3 2025 Earnings Call Highlights: Revenue Surge and Strategic ... - Nov 13th, 2025 10:04 pm
BioHarvest Sciences Inc. (BHST) Reports Q3 Loss, Lags Revenue Estimates - Nov 13th, 2025 3:50 pm
BioHarvest Sciences Reports Third Quarter 2025 Financial Results - Nov 13th, 2025 2:05 pm
Absci Corporation (ABSI) Reports Q3 Loss, Lags Revenue Estimates - Nov 12th, 2025 3:25 pm
BioHarvest Sciences to Attend the Craig-Hallum 16th Annual Alpha Select Conference on November 18, 2025 - Nov 12th, 2025 6:42 am
BioHarvest Sciences Announces Closing of $19.9 Million Upsized Public Offering of Common Stock and Exercise of Underwriter's Option to Purchase Additional Shares - Nov 10th, 2025 2:18 pm
Compugen (CGEN) Reports Q3 Loss, Lags Revenue Estimates - Nov 10th, 2025 6:15 am
BioHarvest Sciences Announces Pricing of $17.4 Million Upsized Public Offering of Common Stock - Nov 7th, 2025 5:30 am
Codexis (CDXS) Reports Q3 Loss, Misses Revenue Estimates - Nov 6th, 2025 6:00 pm
BioHarvest Announces Proposed Public Offering of Common Stock - Nov 6th, 2025 2:37 pm